Adenosine receptor subtype 3 (A3AR) agonists as novel analgesics in chronic neuropathic pain

被引：0
|
作者：
Salvemini, Daniela [1 ]
Janes, Kali [1 ]
Finley, Amanda [1 ]
Doyle, Timothy [1 ]
Chen, Zhoumou [1 ]
Bryant, Leesa [1 ]
Tosh, Dilip [2 ]
Jacobson, Kenneth [2 ]
机构：
[1] St Louis Univ, Sch Med, St Louis, MO USA
[2] NIDDKD, NIH, Bethesda, MD 20892 USA
来源：
FASEB JOURNAL | 2013年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
887.1
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A3 adenosine receptor subtype agonists as novel non- narcotic analgesics for neuropathic pain
    Salvemini, Daniela
    Jacobson, Kenneth
    Tosh, Dilip
    Bennett, Gary
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [2] Central adenosine A3 receptor (A3AR) activation reverses neuropathic pain
    Little, J.
    Chen, Z.
    Ford, A.
    Janes, K.
    Doyle, T.
    Tosh, D.
    Jacobson, K.
    Salvemini, D.
    [J]. JOURNAL OF PAIN, 2014, 15 (04): : S50 - S50
  • [3] Cryo-EM structures of adenosine receptor A3AR bound to selective agonists
    Cai, Hongmin
    Guo, Shimeng
    Xu, Youwei
    Sun, Jun
    Li, Junrui
    Xia, Zhikan
    Jiang, Yi
    Xie, Xin
    Xu, H. Eric
    [J]. NATURE COMMUNICATIONS, 2024, 15 (01)
  • [4] Highly selective A3 adenosine receptor agonists relieve chronic neuropathic pain
    Salvemini, Daniela
    Jacobson, Kenneth A.
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2017, 27 (08) : 967 - 967
  • [5] Reply to 'Highly selective A3 adenosine receptor agonists relieve chronic neuropathic pain'
    Maia, Rodolfo Couto
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2017, 27 (08) : 969 - 969
  • [6] Discovery of next generation A3 adenosine receptor selective agonists for treatment of chronic neuropathic pain
    Tosh, Dilip K.
    Paoletta, Silvia
    Ford, Amanda
    Janes, Kali
    Salvemini, Daniela
    Jacobson, Kenneth A.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [7] Engagement of the GABA to KCC2 Signaling Pathway Contributes to the Analgesic Effects of A3AR Agonists in Neuropathic Pain
    Ford, Amanda
    Castonguay, Annie
    Cottet, Martin
    Little, Joshua W.
    Chen, Zhoumou
    Symons-Liguori, Ashley M.
    Doyle, Timothy
    Egan, Terrance M.
    Vanderah, Todd W.
    De Koninck, Yves
    Tosh, Dilip K.
    Jacobson, Kenneth A.
    Salvemini, Daniela
    [J]. JOURNAL OF NEUROSCIENCE, 2015, 35 (15): : 6057 - 6067
  • [8] Targeting the A3 adenosine receptor (A3AR):: A new approach for cancer treatment
    Fishman, P
    Bar-Yehuda, S
    Madi, L
    [J]. DRUG DEVELOPMENT RESEARCH, 2002, 56 (04) : 547 - 547
  • [9] Supraspinal adenosine A3 receptor (A3AR) activation reverses chemotherapy-induced neuropathic pain through an IL-10 dependent mechanism
    Little, J.
    Janes, K.
    Chen, Z.
    Wahlman, C.
    Tosh, D.
    Jacobson, K.
    Salvemini, D.
    [J]. JOURNAL OF PAIN, 2015, 16 (04): : S57 - S57
  • [10] Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics
    Janes, K.
    Symons-Liguori, A. M.
    Jacobson, K. A.
    Salvemini, D.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2016, 173 (08) : 1253 - 1267
12345